Literature DB >> 3560142

Albendazole in the treatment of hydatid disease.

A Rahemtulla, A D Bryceson, D P McManus, D S Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3560142      PMCID： PMC1290688          DOI： 10.1177/014107688708000220

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  4 in total

1.  Procedures for testing the viability of human hydatid cysts following surgical removal, especially after chemotherapy.

Authors:  J D Smyth; N J Barrett
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

2.  Experience with mebendazole in the treatment of inoperable hydatid disease in England.

Authors:  A D Bryceson; A G Cowie; C Macleod; S White; D Edwards; J D Smyth; D P McManus
Journal:  Trans R Soc Trop Med Hyg       Date:  1982       Impact factor: 2.184

3.  Analysis of benzimidazoles in body fluids by high-performance liquid chromatography.

Authors:  J A Bogan; S Marriner
Journal:  J Pharm Sci       Date:  1980-04       Impact factor: 3.534

4.  Albendazole as a potential treatment for human hydatidosis.

Authors:  A G Saimot; A Meulemans; A C Cremieux; M D Giovanangeli; J M Hay; B Delaitre; J P Coulaud
Journal:  Lancet       Date:  1983-09-17       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.